Latest Insider Transactions at Medtronic PLC (MDT)
This section provides a real-time view of insider transactions for Medtronic PLC (MDT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Medtronic plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Medtronic plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 30
2019
|
Kendall J Powell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
537
-1.64%
|
$47,256
$88.81 P/Share
|
|
Apr 29
2019
|
Richard H Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,002
+2.46%
|
-
|
|
Apr 29
2019
|
Craig Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,002
+6.06%
|
-
|
|
Apr 29
2019
|
Scott C Donnelly Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,002
+14.98%
|
-
|
|
Apr 29
2019
|
Andrea Jo Goldsmith Director |
BUY
Grant, award, or other acquisition
|
Direct |
259
+50.0%
|
-
|
|
Apr 29
2019
|
Randall J Hogan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,002
+5.06%
|
-
|
|
Apr 29
2019
|
Michael O Leavitt Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,002
+9.86%
|
-
|
|
Apr 29
2019
|
James T Lenehan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,002
+3.58%
|
-
|
|
Apr 29
2019
|
Denise M Oleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,002
+3.0%
|
-
|
|
Apr 29
2019
|
Elizabeth G Nabel Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,002
+19.15%
|
-
|
|
Apr 29
2019
|
Kendall J Powell Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,002
+5.76%
|
-
|
|
Apr 01
2019
|
Denise M Oleary Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,671
+4.1%
|
$77,459
$29.96 P/Share
|
|
Mar 20
2019
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Bona fide gift
|
Direct |
2,778
-2.62%
|
-
|
|
Mar 04
2019
|
James T Lenehan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,671
+4.9%
|
$77,459
$29.96 P/Share
|
|
Jan 09
2019
|
Omar Ishrak Executive Chairman |
BUY
Open market or private purchase
|
Direct |
12,000
+2.06%
|
$1,008,000
$84.05 P/Share
|
|
Jan 09
2019
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+3.46%
|
$249,000
$83.87 P/Share
|
|
Dec 01
2018
|
Robert John White EVP & Pres. Medical Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
1,698
-3.45%
|
$164,706
$97.53 P/Share
|
|
Oct 29
2018
|
John R Liddicoat EVP & President of Americas |
BUY
Grant, award, or other acquisition
|
Direct |
2,982
+6.62%
|
-
|
|
Sep 24
2018
|
Geoffrey Martha Chairman and CEO |
SELL
Open market or private sale
|
Direct |
49,799
-45.69%
|
$4,830,503
$97.93 P/Share
|
|
Sep 24
2018
|
Geoffrey Martha Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
49,799
+20.42%
|
$1,792,764
$36.85 P/Share
|
|
Sep 14
2018
|
Omar Ishrak Executive Chairman |
BUY
Bona fide gift
|
Indirect |
10,000
+50.0%
|
-
|
|
Sep 14
2018
|
Omar Ishrak Executive Chairman |
SELL
Bona fide gift
|
Direct |
10,000
-1.77%
|
-
|
|
Sep 07
2018
|
Omar Ishrak Executive Chairman |
BUY
Bona fide gift
|
Direct |
4,580
+0.8%
|
-
|
|
Sep 07
2018
|
Omar Ishrak Executive Chairman |
SELL
Bona fide gift
|
Indirect |
4,580
-37.56%
|
-
|
|
Aug 31
2018
|
Hooman Hakami EVP & Group President Diabetes |
SELL
Open market or private sale
|
Direct |
26,159
-29.46%
|
$2,511,264
$96.29 P/Share
|
|
Aug 31
2018
|
Hooman Hakami EVP & Group President Diabetes |
BUY
Exercise of conversion of derivative security
|
Direct |
26,159
+9.09%
|
$1,621,858
$62.76 P/Share
|
|
Aug 28
2018
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Open market or private sale
|
Direct |
47,176
-30.92%
|
$4,481,720
$95.88 P/Share
|
|
Aug 28
2018
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Exercise of conversion of derivative security
|
Direct |
41,227
+21.27%
|
$1,566,626
$38.81 P/Share
|
|
Aug 23
2018
|
Robert C Pozen Director |
SELL
Open market or private sale
|
Direct |
3,218
-5.01%
|
$305,710
$95.94 P/Share
|
|
Aug 23
2018
|
Robert C Pozen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,484
+3.43%
|
$165,908
$37.05 P/Share
|
|
Aug 23
2018
|
Richard H Anderson Director |
BUY
Open market or private purchase
|
Direct |
2,600
+3.27%
|
$247,000
$95.88 P/Share
|
|
Aug 22
2018
|
Michael J Coyle EVP & Group Pres, Cardiac&Vasc |
SELL
Open market or private sale
|
Direct |
145,544
-42.1%
|
$13,826,680
$95.5 P/Share
|
|
Aug 22
2018
|
Michael J Coyle EVP & Group Pres, Cardiac&Vasc |
BUY
Exercise of conversion of derivative security
|
Direct |
178,219
+17.24%
|
$6,772,322
$38.52 P/Share
|
|
Aug 03
2018
|
Michael J Coyle EVP & Group Pres, Cardiac&Vasc |
SELL
Payment of exercise price or tax liability
|
Direct |
7,585
-4.33%
|
$682,650
$90.48 P/Share
|
|
Aug 03
2018
|
Hooman Hakami EVP & Group President Diabetes |
SELL
Payment of exercise price or tax liability
|
Direct |
4,822
-7.15%
|
$433,980
$90.48 P/Share
|
|
Aug 03
2018
|
Omar Ishrak Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
27,010
-4.59%
|
$2,430,900
$90.48 P/Share
|
|
Aug 03
2018
|
Richard Kuntz SVP & Chief Medical & Science |
SELL
Payment of exercise price or tax liability
|
Direct |
4,987
-4.29%
|
$448,830
$90.48 P/Share
|
|
Aug 03
2018
|
Bradley E Lerman SVP General Counsel & Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
5,818
-9.17%
|
$523,620
$90.48 P/Share
|
|
Aug 03
2018
|
Geoffrey Martha Chairman and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,780
-7.47%
|
$430,200
$90.48 P/Share
|
|
Aug 03
2018
|
Carol A Surface EVP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,156
-8.91%
|
$374,040
$90.48 P/Share
|
|
Aug 03
2018
|
Hoedt Rob Ten EVP and Pres. Global Regions |
SELL
Payment of exercise price or tax liability
|
Direct |
3,954
-5.56%
|
$355,860
$90.48 P/Share
|
|
Aug 03
2018
|
Robert John White EVP & Pres. Medical Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
2,806
-5.41%
|
$252,540
$90.48 P/Share
|
|
Aug 01
2018
|
Robert John White EVP & Pres. Medical Surgical |
SELL
Payment of exercise price or tax liability
|
Direct |
207
-0.4%
|
$18,630
$90.24 P/Share
|
|
Jul 30
2018
|
Michael J Coyle EVP & Group Pres, Cardiac&Vasc |
BUY
Grant, award, or other acquisition
|
Direct |
16,465
+8.6%
|
-
|
|
Jul 30
2018
|
Hooman Hakami EVP & Group President Diabetes |
BUY
Grant, award, or other acquisition
|
Direct |
9,355
+12.34%
|
-
|
|
Jul 30
2018
|
Omar Ishrak Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
50,517
+7.9%
|
-
|
|
Jul 30
2018
|
Richard Kuntz SVP & Chief Medical & Science |
BUY
Grant, award, or other acquisition
|
Direct |
10,104
+7.99%
|
-
|
|
Jul 30
2018
|
Bradley E Lerman SVP General Counsel & Corp Sec |
BUY
Grant, award, or other acquisition
|
Direct |
11,226
+15.03%
|
-
|
|
Jul 30
2018
|
Geoffrey Martha Chairman and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,226
+14.93%
|
-
|
|
Jul 30
2018
|
Karen L Parkhill EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,089
+14.92%
|
-
|